SUN Yimin. Patent analysis and development recommendations for implantable infusion device industry[J]. TIANJIN SCIENCE & TECHNOLOGY, 2025, 52(11): 9-12.
[1] 陈伟,夏旭霞,章月照. 全程规范化护理体系对乳腺癌植入式静脉输液港化疗患者不良反应的影响[J]. 中国性科学,2022,31(1):98-101. [2] 金叶,褚红. 不同部位完全植入式静脉输液港在肿瘤化疗患者中的应用现状[J]. 当代护士(下旬刊),2021,28(3):17-20. [3] CORP. H F. Implantable drug administrator:USD3527220[P]. 1970-09-08. [4] MEDTRONIC INC. Occlusion compensator for implantable peristaltic pump:US19980004208[P]. 2000-03-14. [5] 张亚根.一种具有正压功能的植入治疗泵:20091017-2790.0[P]. 2010-06-02. [6] CORPORATION S. Method for delivering a medication:US1999-0395415[P]. 2001-02-06. [7] ALFRED L C,M. P N,S. M B. Electroactive polymer actuated medication infusion pumps:US20020262991[P]. 2004-04-08. [8] CORPORATION I. Programmable implantable infusate pump:US19820416282[P]. 1984-04-17. [9] TECHNOLOGY I M. Automatic blood monitoring for medication delivery method and apparatus:US74607091A[P]. 1992-05-05. [10] UNIVERSITY J T. Implantable drug delivery catheter system with capillary interface:US20000639612[P]. 2002-10-29.